Amitriptyline is a type of drug called a tricyclic antidepressant. These drugs were originally developed to treat anxiety and depression, but when taken at a low dose they can reduce or stop pain. Amitriptyline works by increasing the amount of serotonin your brain makes.
This report contains market size and forecasts of Amitryptyline in global, including the following market information:
Global Amitryptyline Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Amitryptyline Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Amitryptyline companies in 2021 (%)
The global Amitryptyline market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
10 mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Amitryptyline include Sanis Health and Sivem Pharmaceuticals etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Amitryptyline manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Amitryptyline Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Amitryptyline Market Segment Percentages, by Type, 2021 (%)
10 mg
20 mg
Others
Global Amitryptyline Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Amitryptyline Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Amitryptyline Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Amitryptyline Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Amitryptyline revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Amitryptyline revenues share in global market, 2021 (%)
Key companies Amitryptyline sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Amitryptyline sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanis Health
Sivem Pharmaceuticals